Marketers must pay $2.1M to refund purchasers of Disney- and Marvel heroes-licensed vitamins

As part of its ongoing efforts to stop bogus health claims, the Federal Trade Commission has reached a settlement requiring major marketers of children's vitamins to stop making false and unproven claims that their supplements promote healthy brain and eye development in children.  The companies have agreed to pay $2.1 million to provide refunds to consumers who purchased certain multivitamins in their Disney and Marvel Heroes line.

The FTC charged NBTY, Inc. and two subsidiaries, NatureSmart LLC and Rexall Sundown, Inc., with making deceptive claims about the amount of DHA – an Omega-3 fatty acid – used in their line of Disney- and Marvel Heroes-licensed children's multivitamin gummies and tablets.  The companies also made unsupported claims that a daily serving of the products promotes healthy brain and eye development in children, according to the FTC administrative complaint.

Sold by major retailers such as CVS Pharmacy, Wal-Mart, Target, Walgreens, Kroger, Kmart, Meijer, and Rite Aid, as well as online, the multivitamins featured characters such as the Disney Princesses, Winnie the Pooh, Finding Nemo, and Spider-Man.  Product packaging and print ads promoting the vitamins had bold graphics highlighting that the products contained DHA, but in reality, the products allegedly had only a trace amount of DHA.  While the vitamins' packaging touted the purported health benefits of 100 milligrams of DHA, a daily serving of the Disney and Marvel multivitamins for children ages four years and older contained only one thousandth of that amount (0.1 mg or 100 mcg), according to the FTC's complaint.  

The FTC alleged that the packaging and ads for the Disney and Marvel multivitamins misrepresented that they contained a significant amount of DHA, and that NBTY, NatureSmart, and Rexall Sundown made unsubstantiated claims that the amount of DHA provided by the multivitamins promotes healthy brain and eye development in children.

The settlement:

  • bars NBTY, NatureSmart, and Rexall Sundown from misrepresenting the amount of any ingredient contained in any product.
  • bars them from misrepresenting that any ingredient, including DHA, promotes brain or eye health or provides any other health benefit, unless the claim is true and backed by competent and reliable scientific evidence.
  • specifies that any violations could subject the NBTY, NatureSmart, and Rexall Sundown to civil penalties.

A refund program to distribute the $2.1 million to purchasers of the Disney and Marvel multivitamins will be administered by the FTC.  The agency will reach out to affected consumers in the coming months.

The FTC vote to approve the administrative complaint and proposed consent order was 5-0.  The FTC will publish an announcement regarding the proposed consent order in the Federal Register shortly.  The proposed consent order will be subject to public comment for 30 days, beginning today and continuing through January 14, 2011, after which the FTC will decide whether to make it final.  Consumers can file a public comment online.  Copies of the complaint, the proposed consent agreement, and an analysis of the agreement to aid in public comment are available from both the FTC's website at http://www.ftc.gov and the FTC's Consumer Response Center, Room 130, 600 Pennsylvania Avenue, N.W., Washington, DC 20580.                                                           

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers develop new approach to effectively deliver therapeutics into the brain